ERBB2 and breast cancer: Interestingly, the basal-like and human epidermal growth factor receptor 2 (HER2)-enriched intrinsic breast cancer subtypes were significantly associated with the inflammatory heterocellular subtype (Fig. 1d and Supplementary Table 1e–g), suggesting increased immune phenotype in these subtypes.